Opinion/decision on a Paediatric investigation plan (PIP): Xeljanz, tofacitinib citrate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: EMA/PE/0000226763
Health & Fitness
Opinion/decision on a Paediatric investigation plan (PIP): Xeljanz, tofacitinib citrate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: EMA/PE/0000226763
Opinion/decision on a Paediatric investigation plan (PIP): Xeljanz, tofacitinib citrate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: EMA/PE/0000226763
AAdmin
July 3, 2026
1 min read
